News - Asia-Pacific, Dr Reddy's Laboratories


Popular Filters

Indian drugmakers set to capitalize on Cymbalta generics


Approval for the generic version of Eli Lilly’s Cymbalta duloxetine by the US health regulator (The…

Asia-PacificAurobindo PharmaCymbaltaDr Reddy's LaboratoriesDuloxetine HclEli LillyGenericsHealthcareIndiaLupinMarkets & MarketingNeurologicalPatentsSun Pharmaceutical IndustriesTorrent Pharmaceuticals

Galena Biopharma links with and Dr Reddy's for NeuVax in India


USA-based Galena Biopharma and India’s second-largest drugmaker Dr Reddy's Laboratories have entered…

Asia-PacificDr Reddy's LaboratoriesGalena BioPharmaIndiaLicensingNeuVaxOncologyPharmaceutical

Leading Indian drugmakers eye pharma production in Russia


Several top Indian drugmakers and suppliers, including Dr Reddy's (NYSE: RDY), Ranbaxy (BSE: 500359),…

Asia-PacificAurobindo PharmaCiplaDr Reddy's LaboratoriesEuropeGenericsProductionRanbaxy Laboratories

Dr Reddy's launches Debiopharm's cancer drug Pamorelin LA in India


Independent Swiss biopharma firm Debiopharm Group announced on Friday that, on December 3, Dr. Reddy's…

Asia-PacificDebiopharmDr Reddy's LaboratoriesLicensingMarkets & MarketingOncologyPamorelinPharmaceutical

Back to top